Local recurrence after breast conservation therapy for early stage breast carcinoma
Adri C. Voogd(Eindhoven Cancer Registry), Bert N. van Geel(Rotterdam University of Applied Sciences), Emiel J. Rutgers(The Netherlands Cancer Institute), J.W.W. Coebergh(Erasmus University Rotterdam), Geertjan van Tienhoven, Hans Peterse(The Netherlands Cancer Institute), Annerie Slot(Radiotherapeutisch Instituut Friesland), Patrick Rodrigus(Instituut Verbeeten), Jan J. Jobsen(Medisch Spectrum Twente), M.A. Crommelin(Radboud University Nijmegen), M.F. von Meyenfeldt(Maastricht University Medical Centre), Cornelis JH van de Velde(Leiden University)
Cited by 154
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k